Baldwin Wealth Partners’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
WF
VF
AT
AS
TIM
WTA
Baldwin Wealth Partners's RMD Position: Q2 2026 in Review
Baldwin Wealth Partners reduced its ResMed (RMD) stake by 3% in Q2 2026, selling an estimated $23.4K and leaving 3,668 shares worth $715K. The position accounts for 0.05% of the portfolio, ranked #127.
Baldwin Wealth Partners first reported a position in RMD in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.83M in Q1 2023. 311 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Baldwin Wealth Partners held 3,668 shares of ResMed worth $715K as of Q2 2026.
- Baldwin Wealth Partners sold 113 ResMed shares in Q2 2026, an estimated $23.4K.
- ResMed made up 0.05% of Baldwin Wealth Partners's portfolio in Q2 2026, its #127 holding.
- Baldwin Wealth Partners first reported a position in ResMed in Q1 2020 and has held it in 26 quarters since.
- Baldwin Wealth Partners's ResMed position peaked at $2.83M in Q1 2023.
- 311 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Baldwin Wealth Partners's 13F filing for Q2 2026, filed 14 Jul 2026.